Evidence-Based GI
Evidence-based summary reviews Yadlapati R, Gyawali CP, Masihi M, et al. Optimal Wireless Reflux Monitoring Metrics to Predict Discontinuation of Proton Pump Inhibitor Therapy. Am J Gastroenterol. 2022 Oct 1;117(10):1573-1582. doi.org/10.14309/ajg.0000000000001871.
This summary reviews Wong F, Pappas SC, Curry MP, et al. Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome. N Engl J Med. 2021 Mar 4;384(9):818-828.
Ozanimod for Moderate-Severe Ulcerative Colitis: Rethinking the Top-Down Treatment Algorithm Oriana Damas, MD1 and Philip Schoenfeld, MD, MSEd, MSc (Epi)2…
Continuing Anti-TNF Agents Past 24 Weeks of Pregnancy Associated with Fewer IBD Relapses with No Increase in Adverse Fetal Outcomes…
Donor Stool Product for FMT Decreases Recurrent Clostridioides difficile Infection: RBX2660 Is the First FDA-Approved Live Biotherapeutic Product Colleen R.…
NSAID Use and the Risk of IBD Exacerbations: Fact or Fiction? Philip N. Okafor, MD, MPH1 1Senior Associate Consultant, Department…
Evidence-Based GI: One Year Review Philip Schoenfeld, MD, MSEd, MSc (Epi) Chief (Emeritus), Gastroenterology Section, John D. Dingell VA Medical…
Vonoprazan, a Potassium-Competitive Acid Blocker, Is Superior to Lansoprazole for Managing Erosive Esophagitis Philip Schoenfeld, MD, MSEd, MSc (Epi) Chief…
Reinvestigating the Lack of Association Between Proton Pump Inhibitor Use and Mortality by Accounting for Reverse Causation Ravy K. Vajravelu,…
In Case You Missed It: Surgery is Superior to Medical Therapy for PPI-refractory Heartburn in the “Right” Patients Jennifer…